Repligen (RGEN) Net Cash Flow Growth (3y) (2013 - 2026)
Repligen (RGEN) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.22 Bn | 121.00 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.93 Bn | 44.11 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 33.19 Bn | 31.53 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.58 Bn | 23.15 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.03 Bn | 13.47 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.92 Bn | 13.78 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 36.49% |
| 10 | Repligen | 7.48 Bn | 6.50 Bn | 108.28 Mn | 63.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.77% |
| Dec 31, 2025 | -45.22% |
| Sep 30, 2025 | 67.44% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -55.30% |
| Dec 31, 2024 | -24.78% |
| Sep 30, 2024 | 38.12% |
| Jun 30, 2024 | 11.75% |
| Mar 31, 2024 | 228.52% |
| Dec 31, 2023 | -6.44% |
| Sep 30, 2023 | 69.27% |
| Jun 30, 2023 | 77.91% |
| Mar 31, 2023 | -48.72% |
| Dec 31, 2022 | -97.89% |
| Sep 30, 2022 | -26.99% |
| Jun 30, 2022 | -5.58% |
| Mar 31, 2022 | -69.29% |
| Dec 31, 2021 | -134.41% |
| Sep 30, 2021 | -105.90% |
| Jun 30, 2021 | 69.62% |